Provided by Tiger Trade Technology Pte. Ltd.

VENUS MEDTECH-B

1.170
-0.040-3.31%
Volume:509.00K
Turnover:608.66K
Market Cap:515.98M
PE:-1.08
High:1.250
Open:1.180
Low:1.150
Close:1.210
52wk High:4.040
52wk Low:0.940
Shares:441.01M
HK Float Shares:441.01M
Volume Ratio:0.32
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.086
ROE:-25.85%
ROA:-8.86%
PB:0.29
PE(LYR):-1.08
PS:1.73

Loading ...

Venus Medtech Hangzhou - Subscription Price for New Shares Capped at Hk$2.5 Per Share

THOMSON REUTERS
·
Jul 02

Venus Medtech Hangzhou - Hangzhou Hi-tech, Hangzhou Yingzhiqin May Invest up to Rmb500 Mln in Venus Medtech

THOMSON REUTERS
·
Jul 02

Venus Medtech Shareholders Adopted All AGM Resolutions by Poll Vote

Reuters
·
Jun 25

Venus MedTech Hangzhou announces annual shareholder meeting

Reuters
·
Jun 03

Venus Medtech hosts inaugural Global Partner Summit in Paris

Reuters
·
May 26

HKEX Censures Venus Medtech Former Company Secretary for Oversight in RMB2.48 Billion Director Loans

Bulletin Express
·
May 19

Hong Kong Stock Exchange Disciplines Former Company Secretary of VENUS MEDTECH-B

Stock News
·
May 19

BRIEF-Venus Medtech Hangzhou Says Liqiao Ma Resigns As Executive Director

Reuters
·
May 15

Venus Medtech: Executive Director Liqiao Ma Resigns Effective 15 May 2026

Bulletin Express
·
May 15

Venus Medtech Updates Board and Committee Composition

Bulletin Express
·
May 15

VENUS MEDTECH-B Announces Executive Director Ma Liqiao's Resignation

Stock News
·
May 15

Venus Medtech files list of directors with Hong Kong Stock Exchange

Reuters
·
May 15

Venus MedTech says executive director Ma Liqiao resigns

Reuters
·
May 15

Venus Medtech Hangzhou - Liqiao Ma Resigns as Executive Director Effective May 15, 2026

THOMSON REUTERS
·
May 15

Analysts Expect Venus Medtech (Hangzhou) Inc. (HKG:2500) To Breakeven Soon

Simply Wall St.
·
May 13

VENUS MEDTECH-B Appoints Yip Chui Mui as Company Secretary and Authorized Representative

Stock News
·
May 06

Venus Medtech names Yip Chui Mei company secretary, authorized representative

Reuters
·
May 06

维昇心律2025年营收降至3.07亿元,净亏损同比收窄42.9%,聚焦结构性心脏病全球突破

Bulletin Express
·
Apr 29

Venus MedTech Hangzhou publishes 2025 ESG report

Reuters
·
Apr 29

Venus Medtech: No Share Capital Changes in March 2026, Public Float Fully Compliant

Bulletin Express
·
Apr 08